Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt. Issue 7 (2nd July 2020)

• Record Type: Journal Article
• Authors: Esmat, Gamal; Elbaz, Tamer; Elsharkawy, Aisha; Abdullah, Mohamed; El Kassas, Mohamed
• Is Part Of: Expert review of anti-infective therapy. Volume 18:Issue 7(2020)
• Page Start: 637
• Page End: 642
• Publication Date: 2020-07-02
• Subjects: DAAs -- Egypt -- elimination -- HCV -- screening; Anti-infective agents -- Research -- Periodicals; 616.90461
• DOI: 10.1080/14787210.2020.1758065
• Languages: English
• ISSNs: 1478-7210

Abstract

ABSTRACT: Introduction: Egypt succeeded in establishing a successful model of care for hepatitis C virus (HCV) management in the country with the highest worldwide disease prevalence. The Egyptian ministry of health announced an optimistic goal of near disease elimination. More steps are still required to achieve such a goal. Areas covered: This review covers the efforts made in treatment and prevention of HCV by the Egyptian National Committee for the Control of Viral Hepatitis (NCCVH) with emphasis on the extensive screening program that was able to screen more than 57 million citizens, and future strategies implemented to ensure eradicating the virus from the country. Expert opinion: Despite the great efforts and the proven success in controlling the HCV epidemic in Egypt, some facets of the Egyptian program still need to be upgraded to reach the HCV elimination goal. A significant workload with follow up programs for those who were successfully treated, and treatment failure cases are existing. More enhancement for the currently performed prevention and control measure is missing. Also, we strongly recommend conducting a recent nationwide survey to document the actual infection rates of HCV after all these efforts.